- Subscribe
- Log In More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
- Basket
- Search More
Advanced search
- Latest content
- Current issue
- Archive
- Authors
- About
- Podcasts
Advanced search
- CloseMore
Main menu
- Latest content
- Current issue
- Archive
- Authors
- About
- Podcasts
See AlsoConvert cm to inchesTesla Introduces Model Y Air Mattress for CampingKit CRUZ Optima H. Accent 3/5d (94--00) 932-305I'd like to know if there is a word that you as a native speaker don't know and deem useless. 1-MAGNANİMOUS 2-SWELTERİNG 3-SNUGGLE 4-ACQUAİNTANCE 5-Abbot 6-ABSCESS 7-RETAİN 8-AFFLİCTİON 9-ADJOURN 10-ADO 11-NOSY 12-LACKLUSTRE 13-LAW-ABİDİNG 14-ALLAY(Allevi - Subscribe
- Log in More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
- BMJ Journals
You are here
- Home
- Archive
- Volume 83,Issue Suppl 1
- AB1448 DIFFERENTIATION OF IMMUNE MEDIATED VERSUS NON IMMUNE MEDIATED RHEUMATIC DISEASES BY ONLINE SYMPTOM CHECKER IN REAL-WORLD PATIENTS – MULTIPLE DIAGNOSES AND PARTICULARLY FIBROMYALGIA IS A STUMBLING BLOCK
Email alerts
Article Text
Article menu
- Article Text
- Article info
- Citation Tools
- Share
- Rapid Responses
- Article metrics
- Alerts
Scientific Abstracts
Publication Only
Across diseases
AB1448 DIFFERENTIATION OF IMMUNE MEDIATED VERSUS NON IMMUNE MEDIATED RHEUMATIC DISEASES BY ONLINE SYMPTOM CHECKER IN REAL-WORLD PATIENTS – MULTIPLE DIAGNOSES AND PARTICULARLY FIBROMYALGIA IS A STUMBLING BLOCK
- L. Qin1,
- F. Zegers1,2,
- D. Selani1,3,
- E. B. Van den Akker4,5,
- R. Bos6,7,
- S. Le Cessie2,8,
- I. Gehring9,
- H. K. Glas10,
- M. Johannesson11,
- J. Knitza12,
- L. Mathsson-Alm13,14,
- M. J. T. Reinders2,5,
- E. Steyerberg2,15,
- A. Van Tubergen16,17,
- L. M. Verhoef18,
- B. Axnäs19,
- L. Klareskog20,
- R. Knevel1,21,
- On Behalf of Knevel Lab
- 1Leiden University Medical Center, Department of Rheumatology, Leiden, Netherlands
- 2Leiden University Medical Center, Department of Biomedical Data Sciences, Leiden, Netherlands
- 3Delft University of Technology, Department of Intelligent Systems, Pattern Recognition and Bioinformatics, Delft, Netherlands
- 4Leiden University Medical Center, Leiden Computational Biology, Department of Biomedical Data Sciences, Leiden, Netherlands
- 5Delft University of Technology, The Delft Bioinformatics Lab, Pattern Recognition and Bioinformatics, Delft, Netherlands
- 6Medical Center Leeuwarden, Department of Rheumatology, Leeuwarden, Netherlands
- 7Nij Smellinghe Hospital, Department of Rheumatology, Drachten, Netherlands
- 8Leiden University Medical Center, Department of Clinical Epidemiology, Leiden, Netherlands
- 9Thermo Fisher Scientific, Freiburg, Germany
- 10Reumazorg Zuid West Nederland, Goes, Netherlands
- 11Karolinska Institutet, and Karolinska University Hospital, Department of Medicine Solna, Solna, Sweden
- 12University Hospital of Giessen and Marburg, Philipps-University Marburg, Institute for Digital Medicine, Marburg, Germany
- 13Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden
- 14Thermo Fisher Scientific, Uppsala, Sweden
- 15University Medical Center Rotterdam, Department of Public Health, Rotterdam, Netherlands
- 16Maastricht University Medical Center, Department of Internal Medicine, Division of Rheumatology, Maastricht, Netherlands
- 17Maastricht University, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands
- 18Sint Maartenskliniek, Research Department, Ubbergen, Netherlands
- 19Elsa Science, Stockholm, Sweden
- 20Karolinska Institutet, and Karolinska University hospital, Department of Medicine Solna, Solna, Sweden
- 21Newcastle University Translational and Clinical Research Institute, Rheumatology, Newcastle upon Tyne, United Kingdom
Abstract
Background: Rheumatic? is an online symptom checker developed collaboratively by designers, engineers, clinical experts and patients. It is designed to identify individuals at high risk of developing rheumatic diseases and patients with immune-mediated rheumatic diseases (IRD). After completion of the questionnaire, Rheumatic? gives a weighted score based on expert assessments of the clinical significance of the answers[1]. A previous retrospective study has demonstrated the potential to distinguish IRD from osteoarthritis(OA) and gout, where clinicians filled out the questionnaire based on the medical notes[2]. In order to use a questionnaire in real life, it should be tested on real life participants, as they may describe their symptoms differently than experts.
In order to evaluate the performance of the current Rheumatic? score, to differentiate between IRDs and non-IRDs we conducted a prospective real-world study in the Netherlands and assessed the differences in Rheumatic? total scores between individuals diagnosed with IRD and non-IRD.
Objectives: Examine the difference in scores of Rheumatic? between IRD (Rheumatoid arthritis, Psoriatic arthritis, Myositis, Sjogren’s syndrome, SLE, Spondyloarthritis and Polymyalgia rheumatica) and non-IRD(OA, Gout, Fibromyalgia and other) diagnoses.
Methods: We analyzed data submitted by Dutch participants recruited via multiple channels between July 2021 and July 2022. After completing the online questionnaire Rheumatic? participants received four follow-up surveys at 1 week, 3, 6 and 12 months asking, among other things, for previous and novel diagnoses. The theoretical total score for the participant was determined using the current, expert developed, risk assessment model post collection of all data[1,2].
We used t-test and analysis of variance (ANOVA) to compared the observed differences in mean and median of total scores among these groups.
Results: 8,727 participants were included, of which 6861(79%) were female. The distribution of self-reported diagnoses is shown in Figure 1A. Variations in total scores across diagnosis groups is shown in Figure 1B. Among the participants, 4,146 (48%) did not receive a diagnosis (Table 1), 1,449 (17%) reported an IRD diagnosis, 1,410 (16%) fibromyalgia, and 2,976 (34%) OA or gout. Sex distribution differed between these four diagnostic categories: 78%, 70%, 94% and 80% respectively. 35% had a diagnosis in more than one disease category (Figure 1A). 24% of the people with OA/gout also reported fibromyalgia. For IRDs this was 17.5%.
Patients without a diagnosis had a median score of 210 (Figure 1B). Consistent with the previous study, patients with only an IRD had a significantly higher score than patients with only OA or gout (IRDonly 250 versus AO/Goutonly 207, P<0.001)2. However, this difference was less marked for patients with multiple diagnoses (IRDmultiple 311 and OA/Goutmultiple 305, P=0.57). This was majorly caused by fibromyalgia patients whose median score was even higher than of people with an IRD (330 and 347 for FMonly and FMmultiple).
Conclusion: Our study is the first to test an online symptom checker by following real-life patients. Rheumatic? is capable of capturing different patterns between patients with and without immune-mediated rheumatic diseases by scoring IRDs higher than non-IRDs. However, the magnitude of the difference is obscured by people having multiple diagnoses in particular fibromyalgia.
REFERENCES: [1] Knitza J, et al. DOI: 10.2196/17507.
[2] Knevel R, et al. DOI: 10.3389/fmed.2022.774945.
Table 1. Patient characteristics and self-reported diagnoses.
- Download figure
- Open in new tab
- Download powerpoint
IRD = immune mediate rheumatic diseases, OA = osteoarthritis, FM = fibromyalgia, only = selection of patients with only a diagnosis in the specified category, multiple = diagnoses in multiple disease categories, all = all patients with a specified category diagnosis
- Download figure
- Open in new tab
- Download powerpoint
Figure 1.
Other = joint infection, pseudogout and overload for musculoskeletal system
Acknowledgements: This study was supported by Horizon-EU within the SPIDERR project (activity No.101080711), and the DigiPrevent program (funded in April 2022) from EIT Health. The project has further received funding from the Dutch Organization for Health Research and Development (ZonMw) via the Klinische Fellow No. 40-00703-97-19069, and Open Competition, No. 09120012110075. A special thank you to David Steeman for data management.
Disclosure of Interests: Ling Qin: None declared, Floor Zegers: None declared, Daniyal Selani: None declared, Erik B. van den Akker: None declared, Reinhard Bos: None declared, Saskia Le Cessie: None declared, Isabel Gehring Thermo Fisher Scientific, Herman Kasper Glas: None declared, Martina Johannesson: None declared, Johannes Knitza: None declared, Linda Mathsson-Alm Thermo Fisher Scientific, Marcel J.T. Reinders: None declared, Ewout Steyerberg: None declared, Astrid van Tubergen: None declared, Lise M. Verhoef: None declared, Barbara Axnäs ELSA Science AB, Lars Klareskog: None declared, Rachel Knevel: None declared.
- Observational studies/registry
- Self-management
- Digital health/Measuring health
- Real-world evidence
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- Observational studies/registry
- Self-management
- Digital health/Measuring health
- Real-world evidence
Read the full text or download the PDF:
Subscribe
Log in via Institution
Log in via OpenAthens
Log in using your username and password
Read the full text or download the PDF:
Subscribe
Log in via Institution
Log in via OpenAthens